Advertisement

Topics

Biomerieux Corporate Company Profile

06:14 EST 22nd November 2017 | BioPortfolio

bioMérieux is a worldwide group specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in:Clinical Applications:
the diagnosis of infectious diseases, such as hepatitis, HIV, tuberculosis and respiratory infections, as well as pathologies such as cardiovascular diseases or cancer, based on the analysis of biological samples (blood, saliva, urine …);
Industrial Applications:
the analysis of an industrial sample (food, pharmaceutical and cosmetic products) or an environmental sample (water, air, surface), to determine its microbiological quality.

Location

F-69280 ,
Marcy l'Etoile
France

Contact

Phone: (+33) 04 78 87 20 00
Fax: (+33) 04 78 87 20 90


News Articles [143 Associated News Articles listed on BioPortfolio]

bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19102017] Prices from USD $350

bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investments report include...

bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's bioMerieux SA Mergers Acquisitions MA, Partnerships Alliances and Investments report include...

bioMerieux: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 24082017] Prices from USD $5450

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates b...

Virbac : Availability of the quarterly financial information as of September 30, 2017

Virbac: Availability of the quarterly financial information as of September 30, 2017 Public release - November 14th, 2017 The quarterly financial information as of September 30, 2017 is av...

Ambu A/S: Articles of Association November 2017

  Updated Articles of Association November 2017. Complete Articles of Association November 2017This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate ...

Ambu A/S: Ambu general meeting

Notice is hereby given of the annual general meeting of Ambu A/S, CVR no. 63 64 49 19, which is held on Wednesday, 13 December 2017 at 1 pm at Tivoli Hotel & Congress Center, Arni ...

Ambu A/S: AMBU A/S TO ISSUE UP TO 1,255,000 B SHARES IN A PRIVATE PLACEMENT

The Board of Directors of Ambu A/S ("Ambu") has decided to launch an offering of new B shares at market price (the "Offering").  The Offering will be conducte...

Ambu A/S: Major Shareholder Announcement

In pursuance of §29 of the Danish Securities Trading Act (Værdipapirhandelsloven), Ambu A/S hereby reports that we have been informed by N. P. Louis-Hansen Aps that N. P. Lo...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Reviewing the Emergence of Lactococcus garvieae: A Case of Catheter Associated Urinary Tract Infection Caused by Lactococcus garvieae and Escherichia coli Coinfection.

Lactococcus garvieae is considered a low virulence organism which is rarely associated with human infections. Most of the reported cases have been associated with bacteremia with or without endocardit...

Species distribution and antifungal susceptibility patterns of Candida isolates from a public tertiary teaching hospital in the Eastern Cape Province, South Africa.

Candida species are the leading cause of invasive fungal infections, and over the past decade there has been an increased isolation of drug resistant Candida species. This study aimed to identify the ...

The integration of the molecular methods in the diagnosis algorithm for the poliovirus detection in the sewage water: comparing concentration and detection methods. A Pilot Study.

Introduction Two cases of circulating vaccine-derived poliovirus type 1(cVDPV1), from southwestern Ukraine, bordering Romania, were confirmed in 2015 and the environmental enterovirus surveillance was...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Implementation Assessment and Clinical Utility of the FilmArray® Respiratory Panel (RP) EZ in a CLIA-waived Setting

BioFire Diagnostics, LLC (BioFire; a bioMerieux company), has developed a multiplexed molecular-based in vitro diagnostic platform for infectious disease testing known as the FilmArray. Th...

Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism

Suspected pulmonary embolism (PE) is a frequent clinical problem and remains a diagnostic challenge. The diagnostic approach of PE relies on sequential diagnostic tests, such as plasma D-d...

Companies [98 Associated Companies listed on BioPortfolio]

bioMerieux

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

B. Riley & Co., LLC

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institution...

Stratum Benefit Solutions

Stratum Benefit Solutions, LLC, is a wholly owned business unit of Stratum Group, LLC, and is headquartered in Cleveland, Ohio. Corporate Health IQ ™ is a trademark of Stratu...

Bulletin News, LLC

Bulletin News, LLC is a quiet leader in delivering customized business and political intelligence to top-level corporate and government decision makers. Founded in 1990 and based ...

More Information about "Biomerieux Corporate" on BioPortfolio

We have published hundreds of Biomerieux Corporate news stories on BioPortfolio along with dozens of Biomerieux Corporate Clinical Trials and PubMed Articles about Biomerieux Corporate for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biomerieux Corporate Companies in our database. You can also find out about relevant Biomerieux Corporate Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record